Search research articles
Contact Us
Filters
Showing results (31-40 of 111) with videos related to
Page
of 12
Sort By:
Blood
|
November 10, 2005
Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells
Matthew J Loza, Susan Foster, Stephen P Peters, et al.
Molecular Biology of the Cell
|
August 1, 2014
Rho1 regulates adherens junction remodeling by promoting recycling endosome formation through activation of myosin II
Hanako Yashiro, Andrew J Loza, James B Skeath, et al.
European Journal of Immunology
|
January 29, 2002
Distinction between IL-13+ and IFN-gamma+ natural killer cells and regulation of their pool size by IL-4
Matthew J Loza, Stephen P Peters, James G Zangrilli, et al.
Blood
|
February 7, 2002
Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells
Matthew J Loza, Loris Zamai, Livio Azzoni, et al.
The Journal of Allergy and Clinical Immunology
|
December 25, 2007
Interactive effects of steroids and beta-agonists on accumulation of type 2 T cells
Matthew J Loza, Susan Foster, Stephen P Peters, et al.
Journal of Periodontology
|
September 1, 1996
Validation of quantitative digital subtraction radiography using the electronically guided alignment device/impression technique
E Hausmann, K Allen, J Loza, et al.
Plos One
|
July 26, 2016
Disruption of the Cdc42/Par6/aPKC or Dlg/Scrib/Lgl Polarity Complex Promotes Epithelial Proliferation via Overlapping Mechanisms
Gregory V Schimizzi, Meghan T Maher, Andrew J Loza, et al.
Dalton Transactions (Cambridge, England : 2003)
|
September 22, 2011
Redox-active tetrahydrosalen (salan) complexes of titanium
Mauricio Quiroz-Guzman, Allen G Oliver, Andrew J Loza, et al.
Sangre
|
January 1, 1984
[Isoimmune neonatal thrombopenia caused by anti-PLA1 antibodies. Apropos of 2 cases]
J Loza, A Renovales, A Ribera, et al.
Respiratory Research
|
February 4, 2012
Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease
Matthew J Loza, Rosemary Watt, Frédéric Baribaud, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 111) with videos related to
Sort By:
Page
of 12
Blood
|
November 10, 2005
Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells
Matthew J Loza, Susan Foster, Stephen P Peters, et al.
Molecular Biology of the Cell
|
August 1, 2014
Rho1 regulates adherens junction remodeling by promoting recycling endosome formation through activation of myosin II
Hanako Yashiro, Andrew J Loza, James B Skeath, et al.
European Journal of Immunology
|
January 29, 2002
Distinction between IL-13+ and IFN-gamma+ natural killer cells and regulation of their pool size by IL-4
Matthew J Loza, Stephen P Peters, James G Zangrilli, et al.
Blood
|
February 7, 2002
Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells
Matthew J Loza, Loris Zamai, Livio Azzoni, et al.
The Journal of Allergy and Clinical Immunology
|
December 25, 2007
Interactive effects of steroids and beta-agonists on accumulation of type 2 T cells
Matthew J Loza, Susan Foster, Stephen P Peters, et al.
Journal of Periodontology
|
September 1, 1996
Validation of quantitative digital subtraction radiography using the electronically guided alignment device/impression technique
E Hausmann, K Allen, J Loza, et al.
Plos One
|
July 26, 2016
Disruption of the Cdc42/Par6/aPKC or Dlg/Scrib/Lgl Polarity Complex Promotes Epithelial Proliferation via Overlapping Mechanisms
Gregory V Schimizzi, Meghan T Maher, Andrew J Loza, et al.
Dalton Transactions (Cambridge, England : 2003)
|
September 22, 2011
Redox-active tetrahydrosalen (salan) complexes of titanium
Mauricio Quiroz-Guzman, Allen G Oliver, Andrew J Loza, et al.
Sangre
|
January 1, 1984
[Isoimmune neonatal thrombopenia caused by anti-PLA1 antibodies. Apropos of 2 cases]
J Loza, A Renovales, A Ribera, et al.
Respiratory Research
|
February 4, 2012
Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease
Matthew J Loza, Rosemary Watt, Frédéric Baribaud, et al.
Page
of 12